A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD
NCT02811211 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1894
Last updated 2021-07-06
Summary
This noninterventional study will assess genomic changes in the metabotropic glutamate receptor (mGluR) network in children and adolescents with ADHD.
Conditions
- Attention Deficit Disorder With Hyperactivity
Sponsors & Collaborators
-
Aevi Genomic Medicine, LLC, a Cerecor company
lead INDUSTRY
Eligibility
- Min Age
- 6 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2017-01-06
- Completion
- 2017-01-06
Countries
- United States
Study Locations
More Related Trials
-
Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01238822 ·Status: COMPLETED ·Phase: PHASE4
-
Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00001206 ·Status: COMPLETED
-
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
NCT04421248 ·Status: RECRUITING ·Phase: PHASE4
-
Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
NCT00046059 ·Status: COMPLETED
-
Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD
NCT02430896 ·Status: UNKNOWN
-
Adolescent Changes in Brain and Behavior in Boys and Girls With ADHD
NCT05927506 ·Status: COMPLETED
-
NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study
NCT00595751 ·Status: COMPLETED
-
Epigenetics in ADHD
NCT04860024 ·Status: COMPLETED
-
Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)
NCT00862108 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
NCT00483106 ·Status: COMPLETED ·Phase: PHASE4
-
Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
NCT02623114 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
NCT02286817 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Mechanisms of the Electrophysiological Biomarkers for Response to Methylphenidate Treatment in Children With ADHD
NCT06073470 ·Status: RECRUITING
-
Candidate Gene Screening for Attention Deficit/Hyperactive Disorder (ADHD)
NCT03018574 ·Status: COMPLETED
-
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
NCT04781972 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00409708 ·Status: COMPLETED ·Phase: PHASE2
-
Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers
NCT00026546 ·Status: COMPLETED
-
Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD
NCT06215144 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of ADHD
NCT01682915 ·Status: COMPLETED
-
Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD
NCT02874690 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pharmacogenomics for Improving Pediatric ADHD Treatment
NCT03730870 ·Status: TERMINATED ·Phase: NA
-
Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in ADHD
NCT00756158 ·Status: COMPLETED
-
Study of ADHD Children's Sensitivity to Memory Error Production
NCT05365295 ·Status: COMPLETED ·Phase: NA
-
Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder
NCT00161161 ·Status: COMPLETED
-
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
NCT01709695 ·Status: COMPLETED ·Phase: PHASE4